Literature DB >> 6772662

The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly.

K Hanew, M Kokubun, A Sasaki, T Mouri, K Yoshinaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6772662     DOI： 10.1210/jcem-51-2-292

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  Development of acromegaly in a patient with anorexia nervosa: pathogenetic and diagnostic implications.

Authors:  E de Menis; M Gola; A Giustina
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

2.  The growth hormone responses to L-dopa and TRH in acromegaly.

Authors:  I Jialal; C Naidoo; B C Nathoo; M C Rajput; S M Joubert
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

3.  Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS).

Authors:  K Hanew; A Tanaka
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

4.  Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.

Authors:  A Utsumi; K Hanew; A Sugawara; Y Shimizu; O Murakami; H Ikeda; K Yoshinaga
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

5.  The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.

Authors:  M Giusti; A Lomeo; M Monachesi; G Mazzocchi; R Attanasio; P Sessarego; D Mignone; P Del Monte; G Giordano
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

6.  McCune-Albright syndrome with gigantism and hyperprolactinemia.

Authors:  F Pacini; G Perri; P Bagnolesi; A Cilotti; A Pinchera
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

Review 7.  Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Authors:  P E Battershill; S P Clissold
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 8.  Recent developments in acromegaly: a review.

Authors:  A Jadresic
Journal:  J R Soc Med       Date:  1983-11       Impact factor: 18.000

9.  The effect of long acting somatostatin analogue SMS 201-995 in acromegaly.

Authors:  C J Choi; D B Shin; S W Kim; I M Yang; J W Kim; Y S Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

10.  Investigation of responsiveness to thyrotropin-releasing hormone in growth hormone-producing pituitary adenomas.

Authors:  Sang Ouk Chin; Sang Youl Rhee; Suk Chon; You-Cheol Hwang; In-Kyung Jeong; Seungjoon Oh; Sung-Woon Kim
Journal:  Int J Endocrinol       Date:  2013-11-21       Impact factor: 3.257
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.